136 related articles for article (PubMed ID: 10872924)
1. Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea.
Tamada Y; Fukiage C; Boyle DL; Azuma M; Shearer TR
J Ocul Pharmacol Ther; 2000 Jun; 16(3):271-83. PubMed ID: 10872924
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of experimental angiogenesis of cornea by somatostatin.
Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
4. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.
Klotz O; Park JK; Pleyer U; Hartmann C; Baatz H
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):88-93. PubMed ID: 10664059
[TBL] [Abstract][Full Text] [Related]
6. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
Azar DT
Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human epidermal growth factor and corneal neovascularization.
Nezu E; Ohashi Y; Kinoshita S; Manabe R
Jpn J Ophthalmol; 1992; 36(4):401-6. PubMed ID: 1289616
[TBL] [Abstract][Full Text] [Related]
8. VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.
Oliveira HB; Sakimoto T; Javier JA; Azar DT; Wiegand SJ; Jain S; Chang JH
Eur J Ophthalmol; 2010; 20(1):48-54. PubMed ID: 19882518
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.
Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642
[TBL] [Abstract][Full Text] [Related]
10. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor.
Loughman MS; Chatzistefanou K; Gonzalez EM; Flynn E; Adamis AP; Shing Y; D'Amato RJ; Folkman J
Aust N Z J Ophthalmol; 1996 Aug; 24(3):289-95. PubMed ID: 8913136
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas.
Murata M; Nakagawa M; Takahashi S
Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):584-6. PubMed ID: 9342609
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
[TBL] [Abstract][Full Text] [Related]
14. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
Knighton DR; Phillips GD; Fiegel VD
J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
[TBL] [Abstract][Full Text] [Related]
15. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580
[TBL] [Abstract][Full Text] [Related]
16. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
17. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis.
Mimura T; Han KY; Onguchi T; Chang JH; Kim TI; Kojima T; Zhou Z; Azar DT
J Vasc Res; 2009; 46(6):541-50. PubMed ID: 19571574
[TBL] [Abstract][Full Text] [Related]
18. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
Benelli U; Ross JR; Nardi M; Klintworth GK
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):274-82. PubMed ID: 9040459
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
20. Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P
Lopez ES; Ortiz GA; Potilinski C; Croxatto JO; Gallo JE
Curr Eye Res; 2018 Apr; 43(4):466-473. PubMed ID: 29265937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
